The effect of early diagnosis and treatment on maternal and fetal outcomes in patients with HELLP syndrome;Učinak rane dijagnoze i ishodi liječenja rodilja i fetusa u bolesnica sa sindromom HELLP

Biochemia Medica

Volumn 17, Issue 1, 2007, Pages 60-70

  Wagner, Steven J ^a   Craici, Iasmina M ^a   Hogan, Marie C ^a   Bailey, Kent R ^a   Garovic, Vesna D ^a  

^a Mayo Clinic   (United States)

Author keywords

Fetal outcomes; HELLP syndrome; Intrauterine fetal death; Maternal outcomes; Preeclampsia

Indexed keywords

MAGNESIUM SULFATE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRAIN HEMORRHAGE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FETUS DEATH; FETUS MORTALITY; FETUS OUTCOME; HELLP SYNDROME; HUMAN; INCIDENCE; INFANT MORTALITY; LABOR INDUCTION; LIVER NECROSIS; LUNG EDEMA; MATERNAL MORTALITY; MATERNAL WELFARE; MEDICAL RECORD; PERICARDIAL EFFUSION; PLEURA EFFUSION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANCY TERMINATION; RANDOM SAMPLE; RETINA DETACHMENT; RETROSPECTIVE STUDY; SEIZURE; STATISTICAL SIGNIFICANCE;

EID: 34347391875     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anonymous. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;783(1):S1-S22.
2. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159-67.
3. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol, 1986;155(3):501-9.
4. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162(2):311-6.
5. Sibai BM, Villar MA, Mabie BC. Acute renal failure in hypertensive disorders of pregnancy. Pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol. 1990; 162(3):777-83.
6. Altman D, Carroli G, Duley L, Farrell B, Moodly J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial. a randomised placebo-controlled trial. The Lancet. 2002;359(9321):1877-90.
7. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999;42(2):381-9.
8. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000-6.
9. Jones SL. HELLP! A cry for laboratory assistance. a comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol Mol Hematol. 1998;11(3-4):147-71.
10. Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P, workgroup tA. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care. 2004;8(4).R204-R212.
11. Martin JN, Jr., Blake PG, Lowry SL, Perry KG, Jr., Files JC, Morrison JC. Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol. 1990;76(5 Pt 1):737-41.
12. Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol. 1990;162(5):7141-5.
13. Moodley J. Maternal deaths associated with hypertensive disorders of pregnancy. a population-based study. Hypertens Pregnancy. 2004;23(3):247-56.
14. Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y. Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren Fail. 2004;26(5):557-62.
15. Deruelle P, Coudoux E, Ego A, Houfflin-Debarge V, Codaccioni X, Subtil D. Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol. 2006;125(1):59-65.
16. Araujo AC, Leao MD, Nobrega MH, Bezerra PF, Pereira FV, Dantas EM, et al. Characteristics and treatment of hepatic rupture caused by HELLP syndrome. Am J Obstet Gynecol. 2006;195(1):729-33.
17. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN, Jr. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gyneco. 1994;171(4):1148-53.
18. Martin JN, Jr., Blake PG, Perry KG, Jr., McCoul JF, Hess LW, Martin RW. The natural history of HELLP syndrome. patterns of disease progression and regression. Am J Obstet Gynecol. 1991;164(6 Pt 1):1500-13.
19. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol, 1996;175(2):460-4.
20. August P. Preeclampsia: New Thoughts on an Ancient Problem. J Clin Hypertens. 2000;2:115-23.
21. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355(10):992-1005.
22. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-83.